Stella Xu, Director at Design Therapeutics, Inc. (DSGN), sold 614,880 shares at $20.34 ($11.7M) on 2022-03-18, disclosed to the SEC on 2022-03-22.
Open-market sale of $11.7M DSGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.04 | 552,225 | $10.5M | 89.7% |
| 2 | $20.34 | 13,200 | $268K | 2.3% |
| 3 | $19.01 | 24,000 | $456K | 3.9% |
| 4 | $19.01 | 24,000 | $456K | 3.9% |
| 5 | $18.63 | 1,455 | $27K | 0.2% |
| Total | $19.06 avg | 614,880 |
| $11.7M |
| 100% |
| Filing → |